Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Not stated	2026-04-16		NCT07534371

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing 302 Hospital	32
China-Japan Friendship Hospital	135
First Affiliated Hospital Xi'an Jiaotong University	142
National Cancer Center, China	11
The First Affiliated Hospital of Zhengzhou University	203
West China Hospital	359

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
West China Hospital, Sichuan University	Chengdu	China	129